Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$19M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 38 most recent Form 4 transactions.
| $538.9K |
| -6.6% |
| Open the original filing on SEC.gov |
| Sep 17 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 8,282 | $22.40 | $185.5K | +7.1% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 17,717 | — | — | — | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 55,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 100,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 79,113 | $63.65 | $5M | -40.3% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 93,604 | $63.25 | $5.9M | -32.3% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 17,717 | $26.88 | $476.2K | +6.5% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 55,000 | $15.46 | $850.3K | +25.3% | Open the original filing on SEC.gov |
| Sep 16 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 100,000 | $11.25 | $1.1M | +85.4% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 36,526 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 1,381 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷◆ | 39,283 | — | — | — | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,431 | $65.31 | $93.5K | -1.2% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 1,400 | $63.65 | $89.1K | -1.2% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 27,421 | $62.59 | $1.7M | -18.6% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 71,938 | $62.05 | $4.5M | -32.8% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 36,526 | $8.93 | $326.2K | +20.0% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 1,381 | $22.40 | $30.9K | +0.8% | Open the original filing on SEC.gov |
| Sep 15 | TVTX | Travere Therapeutics, Inc. | MEXER◷ | 39,283 | $26.88 | $1.1M | +27.7% | Open the original filing on SEC.gov |
| May 5 | TVTX | Travere Therapeutics, Inc. | SSELL | 2,174 | $46.65 | $101.4K | -1.5% | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER◆ | 4,250 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| May 4 | TVTX | Travere Therapeutics, Inc. | MEXER | 4,250 | — | — | +3.1% | Open the original filing on SEC.gov |
| Apr 14 | TVTX | Travere Therapeutics, Inc. | SSELL | 7,215 | $41.93 | $302.5K | -5.0% | Open the original filing on SEC.gov |
| Apr 13 | TVTX | Travere Therapeutics, Inc. | AGRANT | 14,000 | — | — | +10.6% | Open the original filing on SEC.gov |
| Feb 3 | TVTX | Travere Therapeutics, Inc. | SSELL | 7,310 | $32.12 | $234.8K | -5.3% | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT◆ | 69,640 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | TVTX | Travere Therapeutics, Inc. | AGRANT | 26,120 | — | — | +23.1% | Open the original filing on SEC.gov |
| Dec 24, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 4,980 | $40.00 | $199.2K | -4.2% | Open the original filing on SEC.gov |
| Nov 3, 2025 | TVTX | Travere Therapeutics, Inc. | GGIFT◷ | 1,078 | — | — | -0.9% | Open the original filing on SEC.gov |
| Oct 31, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 5,591 | $35.00 | $195.7K | -4.5% | Open the original filing on SEC.gov |
| Oct 28, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL◷ | 2,662 | $30.00 | $79.9K | -2.1% | Open the original filing on SEC.gov |
| Sep 23, 2025 | TVTX | Travere Therapeutics, Inc. | GGIFT◷ | 891 | — | — | -0.7% | Open the original filing on SEC.gov |
| May 5, 2025 | TVTX | Travere Therapeutics, Inc. | SSELL | 1,771 | $21.05 | $37.3K | -1.4% | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER◆ | 4,920 | — | — | — | Open the original filing on SEC.gov |
| May 2, 2025 | TVTX | Travere Therapeutics, Inc. | MEXER | 4,920 | — | — | +3.9% | Open the original filing on SEC.gov |